[Autoimmune aspects of myasthenia gravis].
D000172:Acromegaly / Q000150:complications; D000224:Addison Disease / Q000150:complications; D001323:Autoantibodies; D003520:Cyclophosphamide / Q000627:therapeutic use; D048909:Diabetes Complications; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D009157:Myasthenia Gravis / Q000150:complications / Q000188:drug therapy / Q000209:etiology / Q000276:immunology*; D009469:Neuromuscular Junction / Q000187:drug effects; D010276:Parasympatholytics / Q000494:pharmacology; D013934:Thymectomy; D013952:Thymus Hyperplasia / Q000150:complications; D013953:Thymus Neoplasms / Q000150:complications
D001323:Autoantibodies; D007166:Immunosuppressive Agents; D010276:Parasympatholytics; D003520:Cyclophosphamide
Aspectos autoimunes da miasthenia gravis.